Centene Co. (NYSE:CNC – Get Free Report) has been given an average rating of “Moderate Buy” by the fourteen brokerages that are currently covering the company, MarketBeat reports. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $83.92.
CNC has been the topic of a number of recent research reports. Oppenheimer cut their price target on shares of Centene from $110.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, July 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $90.00 price target on shares of Centene in a research report on Tuesday, October 1st. Robert W. Baird lowered their price objective on Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a report on Friday, October 25th. Sanford C. Bernstein decreased their target price on Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a research report on Wednesday, October 30th. Finally, StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 28th.
Insider Activity
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vantage Investment Partners LLC boosted its holdings in shares of Centene by 17.1% in the 3rd quarter. Vantage Investment Partners LLC now owns 683,817 shares of the company’s stock worth $51,478,000 after acquiring an additional 99,904 shares in the last quarter. Diversified Trust Co increased its stake in shares of Centene by 35.8% in the second quarter. Diversified Trust Co now owns 28,009 shares of the company’s stock valued at $1,857,000 after buying an additional 7,385 shares in the last quarter. Bessemer Group Inc. raised its holdings in shares of Centene by 189.6% in the first quarter. Bessemer Group Inc. now owns 24,162 shares of the company’s stock valued at $1,895,000 after buying an additional 15,819 shares during the last quarter. Comerica Bank lifted its position in Centene by 7.3% during the 1st quarter. Comerica Bank now owns 118,597 shares of the company’s stock worth $9,307,000 after buying an additional 8,103 shares in the last quarter. Finally, National Pension Service increased its position in Centene by 15.4% in the 3rd quarter. National Pension Service now owns 1,435,482 shares of the company’s stock valued at $108,063,000 after acquiring an additional 191,768 shares in the last quarter. 93.63% of the stock is owned by institutional investors.
Centene Trading Up 2.0 %
Shares of NYSE CNC opened at $60.30 on Tuesday. The stock has a market cap of $30.44 billion, a price-to-earnings ratio of 10.47, a PEG ratio of 0.79 and a beta of 0.49. The business has a 50 day simple moving average of $66.98 and a 200 day simple moving average of $70.60. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. Centene has a 52 week low of $57.20 and a 52 week high of $81.42.
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- Using the MarketBeat Dividend Tax Calculator
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Investing In Preferred Stock vs. Common Stock
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Best Stocks Under $5.00
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.